Article

Optimal biannual COVID-19 vaccine boosting dates for those aged 65 and over

2025-11-21

Abstract excerpt

<h4>Background: </h4> To mitigate transmission and reduce the morbidity and mortality, the CDC recommends that individuals aged 65 and older receive a second dose of the 2024-2025 COVID-19 vaccine six months after their first booster dose. However, the optimal dates for biannual boosting are unknown. Geographic variation in infection rates throughout the year make it challenging to intuit the best yearly booster a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8f4bebf9-650f-5749-a3b2-27e93e8dec74
DOI: 10.1101/2025.11.20.25340687

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimal biannual COVID-19 vaccine boosting dates for those aged 65 and overDOI 10.1101/2025.11.20.25340687Read

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European RegionSemantic proximity Read

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United StatesSemantic proximity Read

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in CanadaSemantic proximity Read

COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity Read

Cost-effective boosting allocations in the post-Omicron era of COVID-19 managementSemantic proximity Read

Optimal vaccination in aging populations under age-dependent infection fatality risksSemantic proximity Read

Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populationsSemantic proximity Read

Impact of accelerating booster vaccination amidst Omicron surge in the United StatesSemantic proximity Read

Analysis of the Potential Efficacy and Timing of COVID-19 Vaccine on Morbidity and MortalitySemantic proximity Read

Studying Disease Reinfection Rates, Vaccine Efficacy and the Timing of Vaccine Rollout in the context of Infectious DiseasesSemantic proximity Read

Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationSemantic proximity Read

A New Vaccination Assessment Method and Strategy for COVID-19Semantic proximity Read